Goldman Sachs Group »

Gain Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $105k 33k 3.22